Lotte Biologics completes construction of production plant in Incheon, eyes global expansion

The Korea Times - Nov 18, 2026

Lotte Biologics completed construction of its biomanufacturing facility in Incheon, just west of Seoul, on Wednesday, marking a major step in its efforts to become a leading player in the global biopharmaceutical market. A completion ceremony for Plant 1, located at the company's Songdo Bio Campus in Incheon, was attended by the company's co-chief executive officers, James Park and Shin Yoo-yeol, as well as Lotte Group Chairman Shin Dong-bin. "The bio business is Lotte Group's future growth engine and a next-generation industry that will lead Korea's next generation," Chairman Shin said at the event. The production plant, spanning nearly 100,000 square meters, is equipped with key facilities, including a production building and a wastewater treatment facility. It has an annual production capacity of 120,000 liters and is scheduled to begin commercial operations by 2028, according to the company. The facility is expected to provide the company with a large-scale production base in Korea, complementing its manufacturing facility in Syracuse, New York, which it acquired in 2023, the company

Read full article

More News

Scienfinite

Scienfinite publishes articles with a unique approach to inspire our readers with the aim to understand the world and appreciate its everyday awe.